Development of a visual scoring method to determine inflamed, excluded or desert immune phenotype in Non-Small Cell Lung Cancer, Colorectal Cancer, and Urothelial Cancer

Home > Science Hub > Development of a visual scoring method to determine inflamed, excluded or desert immune phenotype in Non-Small Cell Lung Cancer, Colorectal Cancer, and Urothelial Cancer
Back to the list

November 7, 2024

Elizabeth Ross

You might also be interested by

Posters

Development of a Pathologist Scoring Method to Determine Inflamed, Excluded or Desert Immune Phenotype in Carcinoma

March 5, 2025

Histopathology

More info

Scientific Publications

Different PD-L1 Assays Reveal Distinct Immunobiology and Clinical Outcomes in Urothelial Cancer

January 27, 2025

Histopathology

More info

Brochures & Infographics

Immunohistochemistry (IHC) Biomarker List

October 10, 2024

Histopathology

More info

CellTalk Blog

Optimal FFPE Tissue Fixation, Processing, and Embedding: A Comprehensive Guide

September 4, 2024

Histopathology

More info